Madam Chair, I am going to talk about one final subsidiary issue.
I would like us to talk about people affected by thalidomide. A recent announcement extended the coverage period. I was very pleased to hear that, because there are people who were affected by that.
I would like the minister to tell me whether he thinks everyone will be covered. If a few exceptional cases should come to light involving people with substantial evidence, will he agree to cover those exceptions?